Saturday 17 October 2026
Export HKPD’s income statement to Excel — free account
Cellyan Biotechnology Co., Ltd
HKPD Healthcare Medical Distribution
Cellyan Biotechnology Co., Ltd’s revenue for fiscal 2026 (year ended March 2026) was $13.4 million, down 33.9% from fiscal 2025.
0.11
0.00
0.00%
Follow HKPD
A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.
| Mar '26 | Mar '25 | Mar '24 | Dec '23 | Mar '23 | Dec '22 | |
|---|---|---|---|---|---|---|
Cash and Short Term Investments |
0.22 | 3.01 | 0.63 | — | 0.52 | 0.52 |
Receivables |
11.75 | 5.16 | 4.98 | 4.98 | 2.03 | 2.03 |
Inventory |
0.36 | 0.56 | 0.93 | — | 0.19 | 0.19 |
Total current assets |
12.33 | 8.73 | 7.80 | 4.98 | 2.75 | 2.75 |
Property, Plant, Equpment (Net) |
0.06 | 0.11 | 0.10 | — | 0.15 | 0.15 |
Goodwill and Intangible Assets (Total) |
0.08 | 0.10 | 0.03 | — | 0.00 | — |
Total non-current assets |
0.51 | 0.69 | 0.87 | — | 0.66 | 0.15 |
Total Assets |
12.84 | 9.42 | 8.67 | 4.98 | 3.41 | 3.41 |
Accounts Payable |
0.87 | 1.82 | 1.42 | — | 1.55 | — |
Current Part of Debt |
0.88 | 0.37 | 0.22 | — | 0.05 | — |
Current Part of Capital Lease |
0.32 | 0.49 | 0.63 | — | 0.36 | — |
Current Part of Taxes to Pay |
0.02 | 0.11 | 0.22 | — | 0.02 | — |
Other current liabilities |
0.13 | 0.12 | 0.19 | — | 0.27 | — |
Total current liabilities |
3.20 | 2.92 | 3.18 | — | 2.55 | 2.55 |
Long Term Debt (Total) |
0.07 | 1.51 | 1.24 | — | 0.26 | 0.10 |
Non-current Liabilities (Other) |
— | — | — | — | 0.01 | — |
Total non-current liabilities |
0.07 | 1.51 | 1.24 | — | 0.27 | 0.10 |
Total liabilities |
3.26 | 4.43 | 4.41 | — | 2.82 | 2.82 |
Additional Paid In Capital |
8.95 | 3.46 | 3.02 | — | 0.39 | — |
Common Stock (Net) |
0.02 | 0.01 | 0.01 | — | 0.01 | — |
Retained Earnings |
0.37 | 1.50 | 1.53 | — | 0.20 | 0.20 |
Shareholders Equity (Other) |
0.25 | — | (0.30) | — | (0.01) | — |
Common Equity (Total) |
9.58 | 4.99 | 4.25 | — | 0.59 | 0.20 |
Shareholders Equity (Total) |
9.58 | 4.99 | 4.25 | — | 0.59 | 0.59 |
Shareholders Equity and Liabilities (Total) |
12.84 | 9.42 | 8.67 | — | 3.41 | 3.41 |
Shares (Common) |
23.50 | 11.00 | 10.00 | — | 6.84 | — |
Shareholders Equity (Tangible) |
9.51 | 4.89 | 4.22 | 4.98 | 0.58 | 0.59 |
Net Debt |
0.72 | (1.12) | 0.83 | — | (0.21) | (0.42) |
Total Debt |
0.94 | 1.88 | 1.45 | — | 0.31 | 0.10 |
In millions of $ except per-share values · columns are period end dates